InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Wednesday, 09/13/2017 6:05:47 AM

Wednesday, September 13, 2017 6:05:47 AM

Post# of 5907
Heard the R&R presentation - hearing all the details gives much more confidence.

The advantage Tivo has with safety and low side effects and high possibility of Ti + Nivo (opdivo) interim results in Q1-2018 and 3rd line test success - all good milestones

In 6 months we could see some good movement